Last $21.06 USD
Change Today -0.42 / -1.96%
Volume 199.7K
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

aceto corp (ACET) Snapshot

Open
$21.36
Previous Close
$21.48
Day High
$21.43
Day Low
$20.88
52 Week High
05/7/14 - $23.78
52 Week Low
08/4/14 - $16.52
Market Cap
613.0M
Average Volume 10 Days
160.6K
EPS TTM
$0.85
Shares Outstanding
29.1M
EX-Date
03/10/15
P/E TM
24.9x
Dividend
$0.24
Dividend Yield
1.14%
Current Stock Chart for ACETO CORP (ACET)

Related News

No related news articles were found.

aceto corp (ACET) Related Businessweek News

No Related Businessweek News Found

aceto corp (ACET) Details

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products, and specialty chemicals. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and bio chemicals used in pharmaceutical and nutritional preparations. It markets and distributes its generic prescription and over the counter pharmaceutical products to wholesalers, chain drug stores, distributors, and mass market merchandisers. The Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates to various generic drug companies. The Performance Chemicals segment provides specialty chemicals, such as antioxidants, photo initiators, catalysts, curatives, brighteners, and adhesion promoters, which make plastics, surface coatings, textiles, fuels, and lubricants; diazos and couplers used in microfilms and blueprints, as well as in the photo tooling of printed circuit boards; and organic intermediates and colorants. Its raw materials are also used in electronic parts and binders. This segment also offers agricultural protection products comprising herbicides, fungicides, and insecticides, which control weed growth and the spread of insects and microorganisms; and sprout inhibitors for potatoes. The company serves various companies in the industrial chemical, agricultural, and human health and pharmaceutical industries primarily in the United States, Europe, and Asia. Aceto Corporation was founded in 1947 and is headquartered in Port Washington, New York.

270 Employees
Last Reported Date: 09/5/14
Founded in 1947

aceto corp (ACET) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $563.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $341.3K
President of Rising Pharmaceuticals and Chief...
Total Annual Compensation: $338.5K
Senior Vice President of Business Development
Total Annual Compensation: $309.5K
Senior Vice President of Corporate Business D...
Total Annual Compensation: $304.4K
Compensation as of Fiscal Year 2014.

aceto corp (ACET) Key Developments

Aceto Corp.(NasdaqGS:ACET) added to S&P SmallCap 600 Sector Indices – Health Care Sector Index

Aceto Corp.(NasdaqGS:ACET) added to S&P SmallCap 600 Sector Indices – Health Care Sector Index

Aceto Corp.(NasdaqGS:ACET) dropped from S&P SmallCap 600 Sector Indices - Industrials Sector Index

Aceto Corp.(NasdaqGS:ACET) dropped from S&P SmallCap 600 Sector Indices - Industrials Sector Index

Aceto Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2014; Provides Earnings Guidance for Fiscal 2015

Aceto Corporation reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2014. For the quarter, the company's net sales were $123,765,000 against $116,508,000 a year ago. Operating income was $10,672,000 against $10,743,000 a year ago. Income before income taxes was $10,485,000 against $10,730,000 a year ago. Net income was $6,608,000 against $6,755,000 a year ago. Basic and diluted net income per common share was $0.23 against $0.24 a year ago. Adjusted net income (Non-GAAP) was $8,218,000 or $0.28 diluted per share against $7,803,000 or $0.27 diluted per share a year ago. EBITDA for the second quarter was $14.4 million, an increase of $1.5 million over last year or 11%. Bank debt was $108 million at quarter end. For the six months, the company's net sales were $254,568,000 against $245,769,000 a year ago. Operating income was $19,295,000 against $28,159,000 a year ago. Income before income taxes was $18,130,000 against $28,304,000 a year ago. Net income was $11,436,000 against $18,090,000 a year ago. Diluted net income per common share was $0.39 against $0.64 a year ago. Adjusted net income (Non-GAAP) was $14,827,000 or $0.51 diluted per share against $20,261,000 or $0.71 diluted per share a year ago. Six months financial results included $900,000 net income or pardon me, $900,000 charge for net foreign exchange loss, mainly as a result of a mark-to-market valuation of the FX future contracts. For the full year 2015, the company do continue to expect to see a stronger second half of the year compared to the first half. Expects to achieve revenue and profit increases in the second half, primarily as a result of the incremental revenue associated with PACK as well as new generic product launches and price gains at Rising. Now it is expecting both sales and earnings growth for the full year to be in the mid- to high-single digit range. Long-term strategy for growing towards Human Health continues on track and it expects significant earnings growth in Human Health segment this year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACET:US $21.06 USD -0.42

ACET Competitors

Market data is delayed at least 15 minutes.

Company Last Change
American Vanguard Corp $10.86 USD -0.27
Calgon Carbon Corp $20.64 USD -0.23
Cambrex Corp $33.95 USD -0.87
Hawkins Inc $38.93 USD -0.47
KMG Chemicals Inc $21.81 USD -0.11
View Industry Companies
 

Industry Analysis

ACET

Industry Average

Valuation ACET Industry Range
Price/Earnings 27.8x
Price/Sales 1.2x
Price/Book 2.6x
Price/Cash Flow 28.0x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACETO CORP, please visit www.aceto.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.